Zeria Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 11.29% vs 26.57% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 65.96% vs 338.17% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25,082.10",
          "val2": "22,537.70",
          "chgp": "11.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,768.70",
          "val2": "3,865.40",
          "chgp": "49.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "138.80",
          "val2": "113.40",
          "chgp": "22.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-5.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,935.60",
          "val2": "1,768.90",
          "chgp": "65.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "151.80%",
          "val2": "86.60%",
          "chgp": "6.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2.12% vs 15.30% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -15.56% vs 29.54% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "89,159.30",
          "val2": "87,311.10",
          "chgp": "2.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19,721.60",
          "val2": "19,752.30",
          "chgp": "-0.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "501.80",
          "val2": "452.30",
          "chgp": "10.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-208.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,417.10",
          "val2": "9,968.00",
          "chgp": "-15.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.80%",
          "val2": "139.70%",
          "chgp": "-0.09%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

25,082.10

22,537.70

11.29%

Operating Profit (PBDIT) excl Other Income

5,768.70

3,865.40

49.24%

Interest

138.80

113.40

22.40%

Exceptional Items

0.00

-5.00

100.00%

Consolidate Net Profit

2,935.60

1,768.90

65.96%

Operating Profit Margin (Excl OI)

151.80%

86.60%

6.52%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 11.29% vs 26.57% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 65.96% vs 338.17% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

89,159.30

87,311.10

2.12%

Operating Profit (PBDIT) excl Other Income

19,721.60

19,752.30

-0.16%

Interest

501.80

452.30

10.94%

Exceptional Items

0.00

-208.70

100.00%

Consolidate Net Profit

8,417.10

9,968.00

-15.56%

Operating Profit Margin (Excl OI)

138.80%

139.70%

-0.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 2.12% vs 15.30% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -15.56% vs 29.54% in Mar 2025

All Annual Results